Providing affordable medicines in transitional countries

International Journal of Risk and Safety in Medicine

Volumn 15, Issue 1-2, 2002, Pages 127-135

  De Joncheere, Kees ^a   Paal, Tamas ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; NON PRESCRIPTION DRUG;

DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG USE; DRUG UTILIZATION; HEALTH CARE FINANCING; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; REVIEW;

EID: 0036969481     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Pace of change steps up in Central and Eastern Europe, Scrip Magazine (January) (1998).
2. M. McKee and B. Jacobsen, Public health in Europe, Lancet 356 (9230) (2000), 665-670.
3. H.U. Deppe and S. Oreskovic, Back to Europe: back to Bismarck? Int. J. Health Services 26(4) (1996), 777-802.
4. G.I. Petrova, Monitoring of national drug policies - regional comparison between Bulgaria, Romania, former Yugoslav republic of Macedonia and Bosnia Herzegovina, Centr. Eur. J. Public Health 9(4) (2001), 205-213.
5. F.W. Stobbelaar and N. Menabde, Development of the pharmaceutical sector in the Newly Independent States, Eurohealth, 4(6) (special issue winter 1998/9) (1998/1999), 80-84.
6. N. Nazmi Sari and J. Langenbrunner, Consumer out-of-pocket spending for pharmaceuticals in Kazakhstan: implications for sectoral reform, Health Policy and Planning 16(4) (2001), 428-434.
7. WHO/EURO, Proceedings of a seminar on drug financing, reimbursement and pricing policies in CCEE, Budapest, 1997.
8. WHO/EURO, Report of a meeting on policies on pricing and reimbursement of medicines in Europe, November 2000.
9. CADREAC, Proceedings of the first meeting of the drug regulatory authorities in CCEE, National Drug Institute, Sofia, Bulgaria, 1997.
10. CADREAC, Collaborative agreement of drug regulatory authorities of EU associated countries, http://www.cadreac.org, accessed on June 10, 2002.
11. Pan European Regulatory Forum, http://perf.eudra.org/, accessed on June 10, 2002.
12. D.R. King and P. Kanavos, Encouraging the use of generic medicines: implications for transitional economies, Croat. Med. J. 43(4) (2002), 462-469.
13. P. Kanavos, WHO/EURO and LSE, The pharmaceutical market in the Balkans (1997) (unpublished document).
14. R.A. Kiivet et al., Changes in the use of anti-bacterial drugs in the countries of Central and Eastern Europe, Eur. J. Clin. Pharm. 48 (1995), 299-304.
15. R. Škrbić, D. Babić-Djurić, S. Stojisvlević-Šatara et al., The role of drug donations on hospital use of antibiotics during the war and post-war period, Int. J. Risk and Safety in Med. 14 (2001), 31-40.